New drug tested for people whose epilepsy Won't respond to standard treatments
NCT ID NCT06377930
Summary
This study tested an investigational drug called RAP-219 in 30 adults with focal epilepsy that does not respond well to current medications. The main goal was to see if RAP-219 safely reduces the frequency of seizures. Participants had a special implanted brain device that helped researchers measure the drug's effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FOCAL ONSET SEIZURES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Baylor College of Medicine
Houston, Texas, 770300, United States
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Consultants in Epilepsy and Neurology, PLLC
Boise, Idaho, 83702, United States
-
IU Health Neuroscience Center, Goodman Hall
Indianapolis, Indiana, 46202, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
NYU Langone Comprehensive Epilepsy Center
New York, New York, 10016, United States
-
The University of Kansas Medical Center Epilepsy Clinic
Kansas City, Kansas, 66160, United States
-
Thomas Jefferson University
Philadelphia, Pennsylvania, 19107, United States
-
University of Pennsylvania - Department of Neurology
Philadelphia, Pennsylvania, 19104, United States
-
University of Texas Health Science Center, Houston
Houston, Texas, 77030, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
-
Yale University
New Haven, Connecticut, 06519, United States
Conditions
Explore the condition pages connected to this study.